Showing results (121-130 of 186) with videos related to
Sort By:
Pageof 19
Guang Pu Xue Yu Guang Pu Fen Xi = Guang Pu|August 17, 2010
[Studies on cold resistance of hazel determined and analyzed by atomic absorption spectrometry]Xiu-Xia Li, Cheng-Cai Liu, Wei-Dong Zhang, et al.Biomaterials|May 6, 2016
Fibrin degradation by rtPA enhances the delivery of nanotherapeutics to A549 tumors in nude miceBo Zhang, Ting Jiang, Xiaojian She, et al.Journal of Thrombosis and Haemostasis : JTH|December 13, 2024
Clinical and genetic characteristics of 40 patients with nonmuscle myosin heavy chain 9-related disease (MYH9-RD) misdiagnosed as immune thrombocytopenia: a retrospective analysis in ChinaAbdul Rehman Arif, Hu Zhou, Yongjun Fang, et al.Annals of Translational Medicine|March 14, 2022
Safety and efficacy of hetrombopag in patients with chronic immune thrombocytopenia: a single-arm, open-label, multi-center phase 1 studyHeng Mei, Xiequn Chen, Jianfeng Zhou, et al.Iscience|October 3, 2022
Visualizing lymphocytic choriomeningitis virus infection in cells and living miceYuxi Wen, Huan Xu, Weiwei Wan, et al.Oncotarget|October 30, 2016
A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapyWei Shi, Yanxue Yin, Yao Wang, et al.Oncotarget|May 1, 2018
Correction: A tissue factor-cascade-targeted strategy to tumor vasculature: a combination of EGFP-EGF1 conjugation nanoparticles with photodynamic therapyWei Shi, Yanxue Yin, Yao Wang, et al.Molecular Cancer|April 14, 2019
Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activationLisha Ai, Shidai Mu, Chunyan Sun, et al.Human Genetics|September 15, 2012
Novel association of a PROC variant with ischemic stroke in a Chinese Han populationXuan Lu, Liang Tang, Kang Xu, et al.Biomaterials|July 24, 2012
A tissue factor targeted nanomedical system for thrombi-specific drug deliveryWei Shi, Heng Mei, Jun Deng, et al.Pageof 19